Previous Article
Prometic to initiate PBI-4050 pivotal phase 3 clinical trial in Alström Syndrome
Prometic to initiate PBI-4050 pivotal phase 3 clinical trial in Alström Syndrome

The protocol for the Phase 3 clinical trial will be designed to meet expectations from both the U.S and EU ...

Next Article
Prometic announces second annual plasminogen deficiency awareness week
Prometic announces second annual plasminogen deficiency awareness week

This initiative, sponsored by Prometic, aims to raise awareness and improve understanding of this rare dise...